14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
SMTI vs TRNI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Sanara MedTech Inc. (SMTI) is the stronger overall head-to-head candidate over TRNI (TRNI) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SMTI carries a Unified Composite Score of 51.4/100 (HOLD) at $32.55 (N/M Forward P/E, 7.2% operating margin), whereas TRNI carries 44.3/100 (HOLD) at $25.00 (N/M Forward P/E, N/A operating margin).
Technical & Structure Timing Caution: SMTI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile TRNI is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SMTI vs TRNI. Trailing 12-month operating profitability (SMTI 7.2% vs TRNI N/A) and valuation multiples (SMTI N/M vs TRNI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ SMTI vs TRNI Key Questions & Quantitative Answers
As of Nov 20, 2026, Sanara MedTech Inc. (SMTI) is the stronger overall head-to-head candidate over TRNI (TRNI) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SMTI carries a Unified Composite Score of 51.4/100 (HOLD) at $32.55 (N/M Forward P/E, 7.2% operating margin), whereas TRNI carries 44.3/100 (HOLD) at $25.00 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: SMTI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile TRNI is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SMTI leads the Growth & Scale pillar: SMTI posts +8.0% YoY revenue growth and +0.0% YoY earnings growth on $112M TTM revenue (93.0% gross margin, 7.2% operating margin), compared with TRNI at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, SMTI generates $112M in USD-normalized revenue versus N/A for TRNI. In operating R&D and SG&A reinvestment, SMTI deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for TRNI.
SMTI screens cheaper on headline valuation multiples. SMTI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 2.7x EV/Revenue (9.4% EBITDA margin), whereas TRNI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SMTI (-34.9% ROE) versus TRNI (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, SMTI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.30β · 18% Vol realized risk). By comparison, TRNI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.03β · 3% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.